Italy January 24, 2011 Turkey Turkey Central Asia
Turkey Hilmi Sunay
CytoCare continues to be the world’s first and only robotic system proven to ever work in the safe and sterile preparation of both powders and liquid patient-specific Hazardous Intravenous Admixtures, including Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. Now reaching over 60 worldwide installations under contract, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents. While several companies attempted the development of Chemotherapy Robotics as far back as 22 years ago, CytoCare is still the only robot that has been able to break the entry-barrier into the Intravenous Chemotherapy Automation Sector.
Turkey Italy Thailand Malaysia
About Health Robotics:
---------------------------------  Am J Hosp Pharm 46(11): 2286-93 1989 For additional information, please contact: Claudia Flaim, Marketing Coordinator [email protected] Phone: +39-0471-200-372
SOURCE Health Robotics